193 related articles for article (PubMed ID: 11726558)
1. Dramatic phenotypic improvement during pregnancy in a genetic leukodystrophy: estrogen appears to be a critical factor.
Matsuda J; Vanier MT; Saito Y; Suzuki K; Suzuki K
Hum Mol Genet; 2001 Nov; 10(23):2709-15. PubMed ID: 11726558
[TBL] [Abstract][Full Text] [Related]
2. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse.
Matsuda J; Vanier MT; Saito Y; Tohyama J; Suzuki K; Suzuki K
Hum Mol Genet; 2001 May; 10(11):1191-9. PubMed ID: 11371512
[TBL] [Abstract][Full Text] [Related]
3. Genetic ablation of Saposin-D in Krabbe disease eliminates psychosine accumulation but does not significantly improve demyelination.
Watanabe T; Tsuboi K; Matsuda N; Ishizuka Y; Go S; Watanabe E; Ono A; Okamoto Y; Matsuda J
J Neurochem; 2023 Aug; 166(4):720-746. PubMed ID: 37337846
[TBL] [Abstract][Full Text] [Related]
4. Comparative clinico-pathological study of saposin-A-deficient (SAP-A-/-) and Twitcher mice.
Yagi T; Matsuda J; Takikita S; Mohri I; Suzuki K; Suzuki K
J Neuropathol Exp Neurol; 2004 Jul; 63(7):721-34. PubMed ID: 15290897
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy.
Belleri M; Ronca R; Coltrini D; Nico B; Ribatti D; Poliani PL; Giacomini A; Alessi P; Marchesini S; Santos MB; Bongarzone ER; Presta M
Brain; 2013 Sep; 136(Pt 9):2859-75. PubMed ID: 23983033
[TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
7. Globoid cell leukodystrophy (Krabbe's disease): update.
Suzuki K
J Child Neurol; 2003 Sep; 18(9):595-603. PubMed ID: 14572137
[TBL] [Abstract][Full Text] [Related]
8. TNF-receptor 1 deficiency fails to alter the clinical and pathological course in mice with globoid cell leukodystrophy (twitcher mice) but affords protection following LPS challenge.
Pedchenko TV; Bronshteyn IG; LeVine SM
J Neuroimmunol; 2000 Oct; 110(1-2):186-94. PubMed ID: 11024549
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic cell transplantation ameliorates clinical phenotype and progression of the CNS pathology in the mouse model of late onset Krabbe disease.
Yagi T; Matsuda J; Tominaga K; Suzuki K; Suzuki K
J Neuropathol Exp Neurol; 2005 Jul; 64(7):565-75. PubMed ID: 16042308
[TBL] [Abstract][Full Text] [Related]
10. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy.
Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF
Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766
[TBL] [Abstract][Full Text] [Related]
11. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic cell transplantation in murine globoid cell leukodystrophy (the twitcher mouse): effects on levels of galactosylceramidase, psychosine, and galactocerebrosides.
Ichioka T; Kishimoto Y; Brennan S; Santos GW; Yeager AM
Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4259-63. PubMed ID: 2884662
[TBL] [Abstract][Full Text] [Related]
13. Murine model of genetic demyelinating disease: the twitcher mouse.
Suzuki K; Taniike M
Microsc Res Tech; 1995 Oct; 32(3):204-14. PubMed ID: 8527855
[TBL] [Abstract][Full Text] [Related]
14. Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease).
Luzi P; Rafi MA; Zaka M; Curtis M; Vanier MT; Wenger DA
Mol Genet Metab; 2001 Jul; 73(3):211-23. PubMed ID: 11461188
[TBL] [Abstract][Full Text] [Related]
15. A galactose-free diet enriched in soy isoflavones and antioxidants results in delayed onset of symptoms of Krabbe disease in twitcher mice.
Pannuzzo G; Cardile V; Costantino-Ceccarini E; Alvares E; Mazzone D; Perciavalle V
Mol Genet Metab; 2010 Jul; 100(3):234-40. PubMed ID: 20418135
[TBL] [Abstract][Full Text] [Related]
16. Genetic background markedly influences vulnerability of the hippocampal neuronal organization in the "twitcher" mouse model of globoid cell leukodystrophy.
Tominaga K; Matsuda J; Kido M; Naito E; Yokota I; Toida K; Ishimura K; Suzuki K; Kuroda Y
J Neurosci Res; 2004 Aug; 77(4):507-16. PubMed ID: 15264220
[TBL] [Abstract][Full Text] [Related]
17. Krabbe disease: involvement of connexin43 in the apoptotic effects of sphingolipid psychosine on mouse oligodendrocyte precursors.
Graziano AC; Parenti R; Avola R; Cardile V
Apoptosis; 2016 Jan; 21(1):25-35. PubMed ID: 26459425
[TBL] [Abstract][Full Text] [Related]
18. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy.
Rafi MA; Zhi Rao H; Passini MA; Curtis M; Vanier MT; Zaka M; Luzi P; Wolfe JH; Wenger DA
Mol Ther; 2005 May; 11(5):734-44. PubMed ID: 15851012
[TBL] [Abstract][Full Text] [Related]
19. The twitcher mouse: a model for Krabbe disease and for experimental therapies.
Suzuki K; Suzuki K
Brain Pathol; 1995 Jul; 5(3):249-58. PubMed ID: 8520724
[TBL] [Abstract][Full Text] [Related]
20. Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD).
Lee WC; Tsoi YK; Dickey CA; Delucia MW; Dickson DW; Eckman CB
Neurobiol Dis; 2006 Aug; 23(2):273-80. PubMed ID: 16759875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
